Trials / Sponsors / Formycon AG
Formycon AG
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Non Small Cell Lung Cancer, Non-Squamous Non-Small Cell Lung Cancer | Phase 3 | 2024-10-03 |
| Completed | Ocular Safety and Usability Study for FYB203 PFS Age-Related Macular Degeneration, Branch Retinal Vein Occlusion with Macular Edema, Central Retinal Vein Occlusion with Macular Edema | Phase 4 | 2024-09-20 |
| Active Not Recruiting | Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patient Melanoma, Stage II, Melanoma Stage III | Phase 1 | 2024-07-01 |
| Completed | Ocular Safety and Usability Study for FYB201 PFS Age-Related Macular Degeneration, Branch Retinal Vein Occlusion with Macular Edema, Central Retinal Vein Occlusion with Macular Edema | Phase 4 | 2024-06-11 |